AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
A novel CDK20 small molecule inhibitor discovered by artificial intelligence based on an AlphaFold-predicted structure demonstrates the first application of AlphaFold in hit identification for efficient drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Preclinical models of fibrosis demonstrate that inhibition or deletion of JNK has a protective effect against progression of fibrosis [141–144].”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [142]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Lungs of patients with IPF have increased level of activated JNK, which do correspond to severity of fibrosis [141–144].”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [142]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“JNK is increased in cellular stress and leads to inflammatory gene expression and start of the fibrotic process [141–144].”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [142]
Experimental — accuracy not yet measuredIn the citing paper
“This holistic approach represents a paradigm shift toward predictive, preventive, personalized, and participatory (P4) medicine, which could transform cancer care by enabling earlier intervention and more precise therapeutic matching [99,100].”
From Artificial Intelligence in Clinical Oncology: From Productivity Enhancement to Creative Discovery (2025) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Varadi, M., Anyango, S., Deshpande, M., Nair, S., Natassia, C., Yordanova, G., Yuan, D., Stroe, O., Wood, G., Laydon, A., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1061 · Cited by 7,850
Accurate prediction of protein structures and interactions using a 3-track network
Baek, M., DiMaio, F., Anishchenko, I., Dauparas, J., Ovchinnikov, S., Lee, G. R., Wang, J., Cong, Q., Kinch, L. N., Schaeffer, R. D., et al. (2021) · doi:10.1101/2021.06.14.448402 · Cited by 5,549
Self-citationProtein complex prediction with AlphaFold-Multimer
Evans, R., O’Neill, M., Pritzel, A., Antropova, N., Senior, A., Green, T., Žídek, A., Bates, R., Blackwell, S., Yim, J., et al. (2021) · doi:10.1101/2021.10.04.463034 · Cited by 3,808
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0224-x · Cited by 1,573
Self-citationMolecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models
Polykovskiy, D., Zhebrak, A., Sanchez-Lengeling, B., Golovanov, S., Tatanov, O., Belyaev, S., Kurbanov, R., Artamonov, A., Aladinskiy, V., Veselov, M., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565644 · Cited by 849
Self-citationA Structure-Based Drug Discovery Paradigm
Batool, M., Ahmad, B., & Choi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112783 · Cited by 744
A structural biology community assessment of AlphaFold2 applications
Akdel, M., Pires, D. E. V., Pardo, E. P., Jänes, J., Zalevsky, A. O., Mészáros, B., Bryant, P., Good, L. L., Laskowski, R. A., Pozzati, G., et al. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00849-w · Cited by 675
Self-citationZhou, Y., Zhang, Y., Lian, X., Li, F., Wang, C., Zhu, F., Qiu, Y., & Chen, Y. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab953 · Cited by 665
Kadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A., & Zhavoronkov, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00346 · Cited by 587
Self-citationComputed structures of core eukaryotic protein complexes
Humphreys, I. R., Pei, J., Baek, M., Krishnakumar, A., Anishchenko, I., Ovchinnikov, S., Zhang, J., Ness, T. J., Banjade, S., Bagde, S. R., et al. (2021) · Science · doi:10.1126/science.abm4805 · Cited by 542
Applying and improving AlphaFold at CASP14
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.26257 · Cited by 395
Reinforced Adversarial Neural Computer for de Novo Molecular Design
Putin, E., Asadulaev, A., Ivanenkov, Y., Aladinskiy, V., Sanchez-Lengeling, B., Aspuru-Guzik, A., & Zhavoronkov, A. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00690 · Cited by 372
Self-citationIntratumoral heterogeneity and clonal evolution in liver cancer
Losic, B., Craig, A. J., Villacorta-Martin, C., Martins-Filho, S. N., Akers, N., Chen, X., Ahsen, M. E., von Felden, J., Labgaa, I., DʹAvola, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14050-z · Cited by 363
Ravi, R., Noonan, K. A., Pham, V., Bedi, R., Zhavoronkov, A., Ozerov, I. V., Makarev, E., V. Artemov, A., Wysocki, P. T., Mehra, R., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02696-6 · Cited by 325
Self-citationEntangled Conditional Adversarial Autoencoder for de Novo Drug Discovery
Polykovskiy, D., Zhebrak, A., Vetrov, D., Ivanenkov, Y., Aladinskiy, V., Mamoshina, P., Bozdaganyan, M., Aliper, A., Zhavoronkov, A., & Kadurin, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00839 · Cited by 278
Self-citationMamoshina, P., Volosnikova, M., Ozerov, I. V., Putin, E., Skibina, E., Cortese, F., & Zhavoronkov, A. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00242 · Cited by 218
Self-citationAdversarial Threshold Neural Computer for Molecular de Novo Design
Putin, E., Asadulaev, A., Vanhaelen, Q., Ivanenkov, Y., Aladinskaya, A. V., Aliper, A., & Zhavoronkov, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01137 · Cited by 211
Self-citationZhou, J., Liu, M., Sun, H., Feng, Y., Xu, L., Chan, A. W. H., Tong, J. H., Wong, J., Chong, C. C. N., Lai, P. B. S., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314032 · Cited by 201
AI revolutions in biology: The joys and perils of AlphaFold
Perrakis, A., & Sixma, T. K. (2021) · The EMBO Reports · doi:10.15252/embr.202154046 · Cited by 190
AlphaFold heralds a data-driven revolution in biology and medicine
Thornton, J. M., Laskowski, R. A., & Borkakoti, N. (2021) · Nature Medicine · doi:10.1038/s41591-021-01533-0 · Cited by 185
Carrillo-Reixach, J., Torrens, L., Simon‐Coma, M., Royo, L., Domingo-Sàbat, M., Abril‐Fornaguera, J., Akers, N. K., Sala, M., Ragull, S., Arnal, M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.025 · Cited by 159
The Advent of Generative Chemistry
Vanhaelen, Q., Lin, Y.-C., & Zhavoronkov, A. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00088 · Cited by 151
Self-citationNew insights into diagnosis and therapeutic options for proliferative hepatoblastoma
Hooks, K. B., Audoux, J., Fazli, H., Lesjean, S., Ernault, T., Dugot‐Senant, N., Leste‐Lasserre, T., Hagedorn, M., Rousseau, B., Danet, C., et al. (2018) · Hepatology · doi:10.1002/hep.29672 · Cited by 150
Ozerov, I. V., Lezhnina, K. V., Izumchenko, E., Artemov, A. V., Medintsev, S., Vanhaelen, Q., Aliper, A. M., Vijg, J., Osipov, A. N., Labat, I., et al. (2016) · Nature Communications · doi:10.1038/ncomms13427 · Cited by 143
Self-citationFeng, H., Cheng, A. S. L., Tsang, D. P., Li, M. S., Go, M. Y., Cheung, Y. S., Zhao, G.-J., Ng, S. S., Lin, M. C., Yu, J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45967 · Cited by 141
A structural biology community assessment of AlphaFold 2 applications
Akdel, M., Pires, D. E. V., Porta Pardo, E., Jänes, J., Zalevsky, A. O., Mészáros, B., Bryant, P., Good, L. L., Laskowski, R. A., Pozzati, G., et al. (2021) · doi:10.1101/2021.09.26.461876 · Cited by 122
Self-citationPun, F. W., Liu, B. H. M., Long, X., Leung, H. W., Leung, G. H. D., Mewborne, Q. T., Gao, J., Shneyderman, A., Ozerov, I. V., Wang, J., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.914017 · Cited by 115
Self-citationDiscovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7
Marineau, J., Hamman, K. B., Hu, S., Alnemy, S., Mihalich, J., Kabro, A., Whitmore, K. M., Winter, D. K., Roy, S., Ciblat, S., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01171 · Cited by 97
CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells
Wang, Q., Ma, J., Lu, Y., Zhang, S., Huang, J., Chen, J., Bei, J.-X., Yang, K., Wu, G., Huang, K., et al. (2017) · Oncogene · doi:10.1038/onc.2017.161 · Cited by 86
Chiyonobu, N., Shimada, S., Akiyama, Y., Mogushi, K., Itoh, M., Akahoshi, K., Matsumura, S., Ogawa, K., Ono, H., Mitsunori, Y., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.01.012 · Cited by 86
Pun, F. W., Leung, G. H. D., Leung, H. W., Liu, B. H. M., Long, X., Ozerov, I. V., Wang, J., Ren, F., Aliper, A., Izumchenko, E., et al. (2022) · Aging · doi:10.18632/aging.203960 · Cited by 84
Self-citationWang, Y., Cheng, T., Chen, T.-Y., Chang, K., Chuang, V. P., & Kao, K.-J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-815 · Cited by 81
Liu, G., Hou, G., Li, L., Li, Y., Zhou, W., & Liu, L. (2016) · Oncotarget · doi:10.18632/oncotarget.8927 · Cited by 76
APPRIS: selecting functionally important isoforms
Rodriguez, J. M., Pozo, F., Cerdán-Vélez, D., Di Domenico, T., Vázquez, J., & Tress, M. L. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1058 · Cited by 75
Wang, H., Hsieh, T., Huang, S.-Y., Chau, G., Tung, C.-Y., Su, C., & Wu, J. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-736 · Cited by 66
AlphaDesign: A de novo protein design framework based on AlphaFold
Jendrusch, M., Korbel, J. O., & Sadiq, S. K. (2021) · doi:10.1101/2021.10.11.463937 · Cited by 65
Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma
Diaz, G., Engle, R. E., Tice, A. B., Melis, M., Montenegro, S., Rodriguez‐Canales, J., Hanson, J. C., Emmert‐Buck, M. R., Bock, K. W., Moore, I. N., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0012 · Cited by 63
The Cancer Genome Atlas Liver Hepatocellular Carcinoma Collection (TCGA-LIHC)
Erickson, B. J., Kirk, S., Lee, Y., Bathe, O., Kearns, M., Gerdes, C., Rieger-Christ, K., & Lemmerman, J. (2016) · The Cancer Imaging Archive · doi:10.7937/k9/tcia.2016.immqw8uq · Cited by 54
CCRK is a novel signalling hub exploitable in cancer immunotherapy
Mok, M. T. S., Zhou, J., Tang, W., Zeng, X., Oliver, A. W., Ward, S. E., & Cheng, A. S. L. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.008 · Cited by 53
Crystallographic molecular replacement using an in silico‐generated search model of SARS‐CoV‐2 ORF8
Flower, T. G., & Hurley, J. H. (2021) · Protein Science · doi:10.1002/pro.4050 · Cited by 49
Caligiuri, M., Becker, F., Murthi, K. K., Kaplan, F., Dédier, S., Kaufmann, C. M., Machl, A., Zybarth, G., Richard, J., Bockovich, N., et al. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.08.008 · Cited by 45
Kakade, P., Ojha, H., Raimi, O. G., Shaw, A., Waddell, A. D., Ault, J. R., Burel, S., Brockmann, K., Kumar, A., Ahangar, M. S., et al. (2022) · Open Biology · doi:10.1098/rsob.210264 · Cited by 42
Peter, M. F., Depping, P., Schneberger, N., Severi, E., Gatterdam, K., Tindall, S., Durand, A., Heinz, V., Koenig, P.-A., Geyer, M., et al. (2021) · doi:10.1101/2021.12.03.471092 · Cited by 38
Structural and mechanistic analysis of a tripartite ATP-independent periplasmic TRAP transporter
Peter, M. F., Ruland, J. A., Depping, P., Schneberger, N., Severi, E., Moecking, J., Gatterdam, K., Tindall, S., Durand, A., Heinz, V., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31907-y · Cited by 38
Wu, G., Xie, D., Yang, G., Liao, Y.-J., Mai, S., Deng, H.-X., Sze, J., Guan, X., Zeng, Y., Lin, M. C.-M., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24630 · Cited by 31
Structure-based inhibitor design of mutant RAS proteins—a paradigm shift
Nyíri, K., Koppány, G., & Vértessy, B. G. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09914-6 · Cited by 30
Functional characterisation of cell cycle-related kinase (CCRK) in colorectal cancer carcinogenesis
An, X., Ng, S. S., Xie, D., Zeng, Y.-X., Sze, J., Wang, J., Chen, Y., Chow, B., Lü, G., Poon, W. S., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.04.007 · Cited by 29
Self-citationChao, J. L., Korzinkin, M., Zhavoronkov, A. A., Ozerov, I. V., Walker, M. T., Higgins, K. E., Lingen, M. W., Izumchenko, E., & Savage, P. A. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100399 · Cited by 28
Self-citationSen, N., Anishchenko, I., Bordin, N., Sillitoe, I., Velankar, S., Baker, D., & Orengo, C. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac187 · Cited by 25
Jain, A., Chitturi, S., Peters, G. D., & Yip, D. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i9.1132 · Cited by 23
Applications of AlphaFold beyond Protein Structure Prediction
Zhang, Y., Li, P., Pan, F., Liu, H., Hong, P., Liu, X., & Zhang, J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.03.467194 · Cited by 22
Cho, Y. A., Choi, S., Park, S., Park, C.-K., & Ha, S. Y. (2020) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20229 · Cited by 17
Chemistry42: An AI-based platform for de novo molecular designPreprint
Ivanenkov, Y. A., Zhebrak, A., Bezrukov, D. S., Zagribelnyy, B. A., Aladinskiy, V., Polykovskiy, D. A., Lane, E., Kamya, P. R. N., Aliper, A. M., & Zhavoronkov, A. A. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2101.09050 · Cited by 14
Self-citationMueller, D., Totzke, F., Weber, T., Beisenherz-Huss, C., Kraemer, D., Heidemann-Dinger, C., Ketterer, C., Eckert, C., & Kubbutat, M. H. G. (2016) · Cancer Research · doi:10.1158/1538-7445.am2016-2821 · Cited by 4
Lin, C.-M., Yang, J.-H., Lee, H., Lin, Y.-P., Tsai, L., Hsu, C., Luxton, G. W. G., & Hu, C.-F. (2021) · Life · doi:10.3390/life11111230 · Cited by 4
The science news that shaped 2021: Nature’s picks
(2021) · Nature · doi:10.1038/d41586-021-03734-6 · Cited by 1
Research works printed but not linked: 5
- Lin, 2021, Life, 11
- UniProt , UniProt Database , 2022 , https://www.uniprot.org/
- Science's 2021 Breakthrough of the Year: AI brings protein structures to all , https://www.science.org/content/article/breakthrough-2021 , 2022
- Zhavoronkov, 2022, Bioengineering
- M.Kuznetsov and D.Polykovskiy , Proceedings of the AAAI Conference on Artificial Intelligence , 2021 , vol. 35 , pp. 8226–8234
Cited by
Computational approaches streamlining drug discovery
Sadybekov, A. V., & Katritch, V. (2023) · Nature · doi:10.1038/s41586-023-05905-z · Cited by 1,279
Self-Driving Laboratories for Chemistry and Materials Science
Tom, G., Schmid, S. P., Baird, S. G., Cao, Y., Darvish, K., Hao, H., Lo, S., Pablo-García, S., Rajaonson, E. M., Skreta, M., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00055 · Cited by 707
Self-citationAlphaFold2 and its applications in the fields of biology and medicine
Yang, Z., Zeng, X., Zhao, Y., & Chen, R. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01381-z · Cited by 577
Precision treatment in advanced hepatocellular carcinoma
Yang, X., Yang, C., Zhang, S., Geng, H., Zhu, A. X., Bernards, R., Qin, W., Fan, J., Wang, C., & Gao, Q. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.01.007 · Cited by 429
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
Ren, F., Aliper, A., Chen, J., Zhao, H., Rao, S., Kuppe, C., Ozerov, I. V., Zhang, M., Witte, K., Kruse, C., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-024-02143-0 · Cited by 348
“40,41,75–77) to discover the lead inhibitory compounds targeting this kinase.”
Self-citation
Metadata
- Authors
- Ren, F., Ding, X., Zheng, M., Korzinkin, M., Cai, X., Zhu, W., Mantsyzov, A., Aliper, A., Aladinskiy, V., Cao, Z., Kong, S., Long, X., Man Liu, B. H., Liu, Y., Naumov, V., Shneyderman, A., Ozerov, I. V., Wang, J., Pun, F. W., Polykovskiy, D. A., Sun, C., Levitt, M., Aspuru-Guzik, A., & Zhavoronkov, A.
- Affiliations
- Insilico Medicine Shanghai Ltd, Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road. Pudong New District, Shanghai 201203, China
- Insilico Medicine Kong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, Hong Kong, China
- Canadian Institute for Advanced Research (CA)
- Stanford University (US)
- Department of Chemistry, Department of Computer Science, University of Toronto, Vector Institute for Artificial Intelligence, Canadian Institute for Advanced Research, Toronto, Ontario, Canada
- Corresponding author
- Zhavoronkov, Alex
- ORCID
- Venue
- Chemical Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2023
- Volume
- 14
- Issue
- 6
- Pages
- 1443-1452
- ISSN
- 2041-6520 (ISSN-L)
- 2041-6539
- PMC
- PMC9906638
- OpenAlex
- W4313880353
- Cited by
- 365
- References
- 57
- Citations by year
- 2026: 93 · 2025: 118 · 2024: 97 · 2023: 55
- FWCI
- 51.96
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Chemical Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R35GM122543)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- AlphaFold, small molecule inhibitors, hit identification, drug discovery, protein structure prediction, kinase inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.